entertainment -WSS

entertainment

author：entertainment 2025-08-28 13:07:26 - browse：33

Amylyx founders — Justin Klee, left, and Joshua Cohen, both co-founders and co-CEO's of Amylyx Pharmaceuticals. Kayana Szymczak for STAT

The Food and Drug Administration has reversed an internal decision and will now review an experimental treatment for amyotrophic lateral sclerosis — a victory for ALS patients and advocates who have been pressuring regulators to act with more urgency against the fatal, neurodegenerative disease.

Amylyx Pharmaceuticals, a Cambridge, Mass.-based drug maker, said Wednesday that it will submit an application for its ALS treatment, called AMX0035, “in the coming months.”

The filing will be based largely on a single clinical trial of AMX0035 completed one year ago that showed a significant slowing of disease progression in patients with ALS. It’s the same study that FDA officials told Amylyx last April was encouraging, but not convincing enough to review for approval on its own. The company was told by FDA staff to conduct another study, gather more positive data, and then file for approval.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： Be careful with at

focus

WSS

Surge in Apellis stock fueled by confidence in safety of its eye drug

Illinois Supreme Court finds assault weapons ban constitutional

Hospitals are dialing back on venture capital investing

FDA warns medical device makers about rise in fabricated data

In 'major milestone,' FDA approves first cell therapy for solid tumors

AbbVie CEO Gonzalez to step down after a decade fiercely defending Humira

Wikipedia

entertainment

knowledge

How to save PrEP access — and even expand it

Illumina slashes 2023 revenue projections yet again

Medical leaders decry Supreme Court decision on affirmative action

Bipartisan group of lawmakers warns of a rising Chinese threat to U.S. biotech

Activists slam private health insurers over coverage restrictions

Montana youths win climate lawsuit against state for promoting fossil fuels

Virginia high school admissions case could be legal follow

A new drug could help frostbite victims avoid its ravages

The cancer drug shortage isn’t new — and neither are the solutions

Sweeping indictment could be Trump's biggest legal challenge yet: ANALYSIS

leisure time

Timeline: How the deadly wildfires took over Maui day by day

Illinois Supreme Court finds assault weapons ban constitutional

Timeline: How the deadly wildfires took over Maui day by day

Medicare Advantage enrollment grows 7.1% to 33.4 million people

After Optum profits sink, UnitedHealth makes changes

As AI regulations shape up, health tech startups beg for clarity

focus

focus

Wikipedia

knowledge